1. Home
  2. AMCX vs ENGN Comparison

AMCX vs ENGN Comparison

Compare AMCX & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AMC Networks Inc.

AMCX

AMC Networks Inc.

HOLD

Current Price

$9.62

Market Cap

339.5M

ML Signal

HOLD

Logo enGene Holdings Inc.

ENGN

enGene Holdings Inc.

HOLD

Current Price

$8.57

Market Cap

379.3M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMCX
ENGN
Founded
1980
1999
Country
United States
Canada
Employees
N/A
N/A
Industry
Cable & Other Pay Television Services
Sector
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
339.5M
379.3M
IPO Year
2011
N/A

Fundamental Metrics

Financial Performance
Metric
AMCX
ENGN
Price
$9.62
$8.57
Analyst Decision
Sell
Buy
Analyst Count
5
7
Target Price
$6.50
$22.71
AVG Volume (30 Days)
408.8K
314.7K
Earning Date
11-07-2025
12-19-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,316,303,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.41
$2.65
52 Week High
$10.60
$11.14

Technical Indicators

Market Signals
Indicator
AMCX
ENGN
Relative Strength Index (RSI) 63.72 56.36
Support Level $9.59 $7.57
Resistance Level $9.91 $8.47
Average True Range (ATR) 0.37 0.64
MACD -0.02 -0.00
Stochastic Oscillator 61.85 63.69

Price Performance

Historical Comparison
AMCX
ENGN

About AMCX AMC Networks Inc.

AMC Networks owns several linear pay-TV networks, including AMC, WE tv, BBC America, IFC, and SundanceTV. AMC, its most widely distributed network, reached 60 million pay-TV households in the US at the end of 2024. The firm also had nearly 12.5 million US streaming subscribers, with AMC+ as the flagship streaming platform. With both its linear networks and streaming offerings, the firm caters to specific niche audiences. Over the last 15 years, AMC has shifted its focus to original scripted programming from classic movies. It creates content through AMC Studios and also generates revenue from licensing content. Following an international divestiture at the end of 2023, domestic operations make up nearly 90% of total revenue.

About ENGN enGene Holdings Inc.

enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.

Share on Social Networks: